Description

This report, prepared by Antares Consulting Bioindustries Unit has the following objectives:

• Provide a view on the "Proyecto de resolución"of June 28th, 2012 which updates the list of excluded drugs of pharmaceutical services in the Sistema Nacional de Salud (SNS), not to praise or criticize it, but to analyze the actual scope and place it in the European context, providing some remarks that put the magnitude of it in place.
• Identify the challenges for different health system agents set within this action, which changes the paradigm of pharmaceutical policies in Spain and opens a new way to explore from now on.

Authors

Antares Consulting